NEUREVA

FTP

Original and innovative solution services

You are here : Services > In vitro CNS disease models

In vitro CNS disease models

In vitro screening of CNS drug candidates

Medium throughput screening on cortical cultures
Various Primary Cell Cultures: Cortex, Hippocampus, Raphe

Typical Neuroprotection Paradigm on primary culture

 

In vitro screening models available for neuroprotection

  • Glutamate toxicity
  • Hypoglycemia
  • Anoxia

Map2 labeling (fluorescent labeling)

Outcome measures

  • Automated quantification of the percentage of Map2 immunopositive surface (i.e. using the Cellomics® Imager)
  • Counting the number of neurons
  • High throughput analysis by qPCR
  • Determination of EC50